Smith H J, Halliday S E, Earl D C, Stribling D
J Pharmacol Exp Ther. 1983 Jul;226(1):211-6.
Six groups of four dogs were studied under pentobarbital anesthesia. Plasma levels of free fatty acids (FFA), glucose, insulin and lactate were measured after four challenges with isoproterenol (0.125 micrograms/kg/min i.v. for 10 min). In control animals, infusion of isoproterenol elevated plasma FFA, glucose, insulin and lactate, raised heart rate and lowered diastolic blood pressure. Propranolol lowered resting heart rate and blocked all the isoproterenol-induced responses. Atenolol (beta-1-selective antagonist) slowed resting heart rate and blocked FFA and heart rate responses. ICI 118,551 (beta-2-selective antagonist) blocked the glucose, insulin and lactate responses and the fall in diastolic blood pressure. Selectivity was lost at higher doses. ICI 141,292 (potent beta-1-selective antagonist and modest partial agonist) exhibited beta-1-selective blockade against both cardiovascular (heart rate) and metabolic (FFA) receptors. Partial agonist activity was also beta-1-selective, but there was no evidence of agonist activity at the metabolic receptors.
六组,每组四只狗,在戊巴比妥麻醉下进行研究。用异丙肾上腺素(0.125微克/千克/分钟静脉注射,持续10分钟)进行四次刺激后,测量血浆中游离脂肪酸(FFA)、葡萄糖、胰岛素和乳酸的水平。在对照动物中,输注异丙肾上腺素可提高血浆FFA、葡萄糖、胰岛素和乳酸水平,提高心率并降低舒张压。普萘洛尔降低静息心率并阻断所有异丙肾上腺素诱导的反应。阿替洛尔(β1选择性拮抗剂)减慢静息心率并阻断FFA和心率反应。ICI 118,551(β2选择性拮抗剂)阻断葡萄糖、胰岛素和乳酸反应以及舒张压下降。在较高剂量时选择性丧失。ICI 141,292(强效β1选择性拮抗剂和适度部分激动剂)对心血管(心率)和代谢(FFA)受体均表现出β1选择性阻断作用。部分激动剂活性也是β1选择性的,但在代谢受体上没有激动剂活性的证据。